Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,536 | 8,504 | 163 | 303 | 0 |
| TOTAL | $7,556 | $8,527 | $193 | $306 | $0 |
| Non-Current Assets | |||||
| PPE Net | 59 | 8 | N/A | N/A | N/A |
| Other Non-Current Assets | 14 | 0 | 0 | 0 | 0 |
| TOTAL | $73 | $8 | $N/A | $N/A | $N/A |
| Total Assets | $7,630 | $8,535 | $193 | $306 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 75 | 427 | 308 | 307 | 0 |
| Accounts payable and accrued liabilities | 483 | 209 | 189 | 182 | 0 |
| Accrued Expenses | 56 | 138 | 44 | 64 | 0 |
| Other current liabilities | N/A | N/A | 18 | 20 | 0 |
| TOTAL | $614 | $873 | $647 | $649 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 212 | 331 | 331 | 0 |
| TOTAL | $N/A | $212 | $331 | $331 | $N/A |
| Total Liabilities | $614 | $1,084 | $978 | $980 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 859 | 859 | 17 | N/A | N/A |
| Common Shares | 3 | 3 | 5 | 1 | 0 |
| Retained earnings | -3,167 | -2,507 | -2,003 | -1,887 | 0 |
| Other shareholders' equity | 0 | 0 | -4 | 0 | 0 |
| TOTAL | $7,016 | $7,450 | $-785 | $-675 | $0 |
| Total Liabilities And Equity | $7,630 | $8,535 | $193 | $306 | $0 |